Department of Health and Human Services - www.hhs.gov
Department of Health and Human Services - www.hhs.gov
healthfinder.gov - A Service of the National Health Information Center, U.S. Department of Health and Human Services

 

healthfinder.gov Home   |   About Us   |   News   |   Health Library   |   Consumer Guides   |   Organizations   |   En Español   |   Kids   |   Contact Us

Home > News

Blocking Drug-Related Memories May Prevent Relapses

Animal brain receptor study suggests new treatments for addiction in humans.

  • E-mail this article
  • Subscribe to news
  • Printer friendly version
  • (SOURCE: Society for Neuroscience, news release, Aug. 12, 2008)

    WEDNESDAY, Aug. 13 (HealthDay News) -- It may be possible to prevent a drug addiction relapse by disrupting the brain's attempts to retrieve drug-associated memories, according to new research.

    U.K. researchers reduced drug-seeking behaviors in rats by blocking their brain's NMDA-type glutamate receptor, which is vital for learning and memory, during the recall of drug-associated memories. Researchers have known that recalling memories linked to previous drug use, such as environmental cues, can cause recovering drug addicts to relapse.

    The findings are published in the Aug. 13 issue of The Journal of Neuroscience.

    In the study, researchers at the University of Cambridge trained rats to associate a light going on with receiving a dose of cocaine. They "reactivated" the memory by exposing the rats to the light without the cocaine infusion. Later, the rats continued to perform behaviors that turned on the light or learned to perform new behaviors to try to get more cocaine.

    The rats' cocaine-seeking behaviors were reduced after the researchers gave the animals a chemical that interfered with the NMDA-type glutamate receptor. When the single treatment was given just prior to the reactivation session, it reduced or even stopped drug-seeking behavior for up to a month; however, when given after or without the reactivation session, it had no effect on subsequent drug-seeking behaviors.

    The findings suggest combining existing therapy with properly timed use of NMDA receptor inhibitors may help addicts kick their habits. The U.S. Food and Drug Administration already has approved several NMDA receptor inhibitors, including the cough suppressant dextramethorphan and the Alzheimer's disease drug memantine.

    More information

    The Center for Substance Abuse Treatment has more about dealing with addiction.

    Copyright © 2008 ScoutNews, LLC. All rights reserved.  External Links Disclaimer Logo

    HealthDayNews articles are derived from various sources and do not reflect federal policy. healthfinder.gov does not endorse opinions, products, or services that may appear in news stories. For more information on health topics in the news, visit the healthfinder.gov health library.

    healthfinder.gov logo USA dot Gov: The U.S. Government’s Official Web Portal
    footer shadow